IMDA Quarterly Education Session

IMDA Quarterly Education Session 

Saturday May 18th, 10:00 AM- 3:00 PM

Registration Fee $75.00 per person, FREE for students/fellows

Agenda:

10:00 AM-11:00 AM  Antibiotic Stewardship - Jarrett Amsden, PharmD, BCPS

11:15 AM-12:15 PM Opioid Use and Challenges in Subacute & Long-Term Care - Monica Ott, MD, CMD

12:15 PM- 12:45 PM Lunch & Exhibits

12:45 PM-1:45 PM New Drug Approvals: Safety and Efficacy in Older Adults- Sam Gurevitz, PharmD

2:00 PM- 3:00 PM Deprescribing Panel- Cheryl Ditzler NP; Sam Gurevitz, PharmD; Kristi Lieb MD, CMD; John Riley, MD, CMD

Learning Objectives: At the conclusion of the program, participants will be able to describe best practices for patient care in post-acute and long-term care, summarize clinical and practice updates as related to the post-acute and long-term care setting, and describe methods to support teamwork through inter-professional teams in the post-acute care long-term care environment that are designed to result in quality care and increased satisfaction of the residents, their family and the staff.

CME: This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of Indiana University School of Medicine and Indiana University Health. The Indiana University School of Medicine is accredited by the ACCME to provide continuing medical education for physicians. Designation Statement:  The Indiana University School of Medicine designates this live activity for a maximum of 4.0 AMA PRA Category 1 Credit(s)™.  Physicians should only claim credit commensurate with the extent of their participation in the activity. Faculty Disclosure Statement:  In accordance with the Accreditation Council for Continuing Medical Education (ACCME) Standards for Commercial Support, educational programs sponsored by Indiana University School of Medicine (IUSM) must demonstrate balance, independence, objectivity, and scientific rigor.  All faculty, authors, editors, and planning committee members participating in an IUSM-sponsored activity are required to disclose any relevant financial interest or other relationship with the manufacturer(s) of any commercial product(s) and/or provider(s) of commercial services that are discussed in an educational activity.  Statements of disclosure have been obtained from this speaker.  

CMD: This live activity has been pre-approved by the American Board of Post-Acute and Long-Term Care Medicine (ABPLM) for a total of 1 management hour and 3 clinical hours toward certification as a Certified Medical Director (CMD) in post-acute and long-term care medicine. The CMD program is administered by the ABPLM.  Each physician should claim only those hours of credit actually spent on the activity. 

Nursing Contact Hours: This continuing education activity was approved by the Ohio Nurses Association for 4 contact hours including 4 contact hours of advanced pharmacotherapy. The Ohio Nurses Association is accredited as an approver of continuing nursing education by the American Nurses Credentialing Center's Commission on Accreditation. (OBN-001-91)